Drug Shortage Report for MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL

Last updated on 2019-07-10 History
Report ID 88291
Drug Identification Number 02443902
Brand name MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL
Common or Proper name EMTRICITABINE/TENOFOVIR DISOPROXIL
Company Name MYLAN PHARMACEUTICALS ULC
Active Ingredient(s) TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE
Strength(s) 300MG 200MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30 BT
ATC code J05AR
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-07-03
Actual start date
Estimated end date Unknown
Actual end date 2019-07-09
Shortage status Resolved
Updated date 2019-07-10
Company comments
Health Canada comments
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2019-07-10 English Compare
v5 2019-07-09 French Compare
v4 2019-07-09 English Compare
v3 2019-07-04 English Compare
v2 2019-07-03 French Compare
v1 2019-07-03 English Compare